Elkfork Partners’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | $374K | Hold |
4,648
| – | – | 0.01% | 661 |
|
|
2019
Q2 | $337K | Sell |
4,648
-840
| -15% | -$60.9K | 0.01% | 692 |
|
|
2019
Q1 | $513K | Sell |
5,488
-56
| -1% | -$5.24K | 0.01% | 553 |
|
|
2018
Q4 | $404K | Sell |
5,544
-53,340
| -91% | -$3.89M | 0.01% | 576 |
|
|
2018
Q3 | $5.15M | Sell |
58,884
-5,908
| -9% | -$517K | 0.12% | 168 |
|
|
2018
Q2 | $6.38M | Buy |
64,792
+15,484
| +31% | +$1.52M | 0.16% | 133 |
|
|
2018
Q1 | $5.87M | Buy |
+49,308
| New | +$5.87M | 0.16% | 142 |
|